Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrations.

Bruin SC, de Ronde JJ, Wiering B, Braaf LM, de Wilt JH, Vincent AD, van Velthuysen ML, Ruers TJ, Wessels LF, van't Veer LJ.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S560-9. doi: 10.1245/s10434-013-2985-7. Epub 2013 Jun 20.

PMID:
23783809
2.

[Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].

Konopke R, Volk A, Gastmeier J, Ehehalt F, Distler M, Saeger HD, Kersting S.

Zentralbl Chir. 2014 Apr;139(2):226-34. doi: 10.1055/s-0032-1328565. Epub 2013 Jul 11. German.

PMID:
23846538
3.

Colorectal liver metastases: hepatic pedicle clamping during hepatectomy reduces the incidence of tumor recurrence in selected patients. Case-matched analysis.

De Carlis L, Di Sandro S, Giacomoni A, Mihaylov P, Lauterio A, Mangoni I, Cusumano C, Poli C, Tripepi M, Bencardino K.

Eur J Surg Oncol. 2013 Jul;39(7):726-33. doi: 10.1016/j.ejso.2013.03.015. Epub 2013 Apr 18.

PMID:
23601983
4.

[Diagnosis and treatment of colorectal liver metastases - workflow].

Grundmann RT, Hermanek P, Merkel S, Germer CT, Grundmann RT, Hauss J, Henne-Bruns D, Herfarth K, Hermanek P, Hopt UT, Junginger T, Klar E, Klempnauer J, Knapp WH, Kraus M, Lang H, Link KH, Löhe F, Merkel S, Oldhafer KJ, Raab HR, Rau HG, Reinacher-Schick A, Ricke J, Roder J, Schäfer AO, Schlitt HJ, Schön MR, Stippel D, Tannapfel A, Tatsch K, Vogl TJ; Arbeitsgruppe Workflow Diagnostik und Therapie von Lebermetastasen kolorektaler Karzinome..

Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796. Review. German.

PMID:
18563694
5.

Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.

Yamada H, Kondo S, Okushiba S, Morikawa T, Katoh H.

World J Surg. 2001 Sep;25(9):1129-33.

PMID:
11571947
6.

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghémard O, Levi F, Bismuth H.

Ann Surg. 2004 Oct;240(4):644-57; discussion 657-8.

7.

Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.

Bruin SC, Klijn C, Liefers GJ, Braaf LM, Joosse SA, van Beers EH, Verwaal VJ, Morreau H, Wessels LF, van Velthuysen ML, Tollenaar RA, Van't Veer LJ.

BMC Cancer. 2010 Dec 2;10:662. doi: 10.1186/1471-2407-10-662.

8.

Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.

Battula N, Tsapralis D, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, Bramhall S, Mirza D, Marudanayagam R.

HPB (Oxford). 2014 Feb;16(2):157-63. doi: 10.1111/hpb.12096. Epub 2013 Mar 27.

9.

Survival after repeat hepatic resection for recurrent colorectal metastases.

Chiappa A, Zbar AP, Biella F, Staudacher C.

Hepatogastroenterology. 1999 Mar-Apr;46(26):1065-70.

PMID:
10370668
10.

Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.

Angelsen JH, Viste A, Løes IM, Eide GE, Hoem D, Sorbye H, Horn A.

World J Surg Oncol. 2015 Dec 3;13:328. doi: 10.1186/s12957-015-0738-8.

11.

SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases.

López-Gómez M, Moreno-Rubio J, Suárez-García I, Cejas P, Madero R, Casado E, Jiménez A, Sereno M, Gómez-Raposo C, Zambrana F, Merino M, Fernández-Luengas D, Feliu J.

Clin Transl Oncol. 2015 Feb;17(2):133-8. doi: 10.1007/s12094-014-1202-x. Epub 2014 Jul 25.

PMID:
25060566
12.

Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.

Margonis GA, Kim Y, Sasaki K, Samaha M, Amini N, Pawlik TM.

Cancer. 2016 Sep 1;122(17):2698-707. doi: 10.1002/cncr.30085. Epub 2016 May 31.

PMID:
27244540
13.

Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?

Lalmahomed ZS, Ayez N, van der Pool AE, Verheij J, IJzermans JN, Verhoef C.

World J Surg. 2011 Mar;35(3):656-61. doi: 10.1007/s00268-010-0890-9.

14.

Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.

Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC.

Ann Surg Oncol. 2008 Jan;15(1):227-32. Epub 2007 Sep 20.

PMID:
17882491
15.

Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.

Hayashi M, Inoue Y, Komeda K, Shimizu T, Asakuma M, Hirokawa F, Miyamoto Y, Okuda J, Takeshita A, Shibayama Y, Tanigawa N.

BMC Surg. 2010 Sep 27;10:27. doi: 10.1186/1471-2482-10-27.

16.

Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.

Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, Mochizuki H, Yamamoto J.

Dis Colon Rectum. 2003 Oct;46(10 Suppl):S22-31.

PMID:
14530655
17.

Surgical treatment for extrahepatic recurrence after hepatectomy for colorectal metastases.

Yoshidome H, Ito H, Kimura F, Ambiru S, Shimizu H, Togawa A, Ohtsuka M, Kato A, Nukui Y, Miyazaki M.

Hepatogastroenterology. 2004 Nov-Dec;51(60):1805-9.

PMID:
15532831
18.

Liver resection for colorectal metastases: the third hepatectomy.

Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H.

Ann Surg. 2003 Dec;238(6):871-83; discussion 883-4.

19.

Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis.

Martí J, Modolo MM, Fuster J, Comas J, Cosa R, Ferrer J, Molina V, Romero J, Fondevila C, Charco R, García-Valdecasas JC.

World J Gastroenterol. 2009 Jun 7;15(21):2587-94.

20.

The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.

Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, Imoto S, Kawano S, Yamaguchi R, Toh H, Iinuma H, Ishimaru S, Ishii H, Suzuki S, Tokudome S, Watanabe M, Tanaka J, Kudo SE, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Miyano S, Sugihara K, Mori M.

Ann Surg Oncol. 2013 Apr;20(4):1395-402. doi: 10.1245/s10434-012-2657-z. Epub 2012 Sep 14.

PMID:
22976378

Supplemental Content

Support Center